This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE

The project will be conducted in four distinct stages. Firstly, evidence synthesis will be carried out to gather and analyze available data on the topic. Following this, a discussion among physicians will be facilitated to understand the knowledge gaps among rheumatologists and other specialists regarding SLE. Subsequently, consensus will be sought among a select group of rheumatologists on various aspects related to patient care, unmet medical needs, and implementation of new technologies. Finally, the findings and conclusions from these stages will be used to inform the development and publication of scientific papers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Systemic Lupus Erythematosus Arthritis Autoimmune Diseases Bone Diseases Bone Diseases, Infectious Connective Tissue Diseases Immune System Diseases Infections Joint Diseases Lupus Erythematosus, Systemic Musculoskeletal Diseases Skin and Connective Tissue Diseases Spinal Diseases Spondylitis

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

São Paulo, Brazil

About this study

This study has as geral objective understanding the currently unmet development needs of rheumatologists and other specialists involved in the care of patients with SLE, from a comparative perspective with other rheumatic diseases. The goal is to increase the engagement of these professionals in the discussion and management of patients and sécific objectives, compare the currently available evidence on SLE and three other rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis); Promote discussions to understand the knowledge development needs of rheumatologists regarding SLE; Generate a consensus on the equity of rheumatic diseases in relation to public policies, guidelines, registries, patient association mobilization, patient journey, time to diagnosis, and available medications with access to treatment and, Promote awareness and knowledge through scientific publications about SLE.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All the patients with SLE registered in DataSUS, in the outpatient system (SIA) and in the Hospital System (SIH) from 2019 to 2022

Exclusion criteria

Not applicable

Treatment and study plan

Primary outcomes

Understand the difficulties faced by patients with SLE and identify gaps in diagnosis and treatment

Time frame: through study completion, an average of 3 months

Prepare an evidence synthesis using available data, discuss the topic with medical experts to understand knowledge gaps among rheumatologists and other professionals regarding SLE, and build consensus among a group on various aspects related to patient care, unmet medical needs, and implementation of new technologies

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Generating Evidence Study for Systemic Lupus Erythematosus Using Different Types of Methodologies

Acronym: LESBRA

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Nov 21, 2024
Registry last updated: Dec 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed